Skip to main content
Premium Trial:

Request an Annual Quote

Steve Lombardi, Stan Lapidus, Bill Efcavitch, Marc Levine, Stan Letovsky

Helicos BioSciences last month appointed president and chief operating officer Steve Lombardi to be its new CEO, while current CEO Stan Lapidus will remain chairman of Helicos’ board of directors.
Lombardi will retain his position as president of the company while taking on the new position, Helicos said. He previously served as vice president of Applied Biosystems’ DNA sequencing and genetic analysis unit, and as senior vice president at Affymetrix.
In addition, Helicos recently named Bill Efcavitch to be chief technology officer, Marc Levine to be senior VP of product development, and Stan Letovsky as VP for scientific informatics.

Efcavitch was promoted from VP of product development, and he previously spent 24 years at Applied Biosystems. Levine previously was involved in commercialization and development of capital equipment at Teradyne. Letovsky spent 20 years working in industrial bioinformatics and had management roles at Codon Devices, Millennium Pharmaceuticals, and Monsanto.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.